Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma

This review focuses on the use of chimeric antigen receptor (CAR)-T cell therapy to treat non-Hodgkin’s lymphoma (NHL), a classification of heterogeneous malignant neoplasms of the lymphoid tissue. Despite various conventional and multidrug chemotherapies, the poor prognosis for NHL patients remain...

Full description

Bibliographic Details
Main Authors: Maria Giraudo, Zachary Jackson, Indrani Das, Olubukola Abiona, David Wald
Format: Article
Language:English
Published: Case Western Reserve University 2024-03-01
Series:Pathogens and Immunity
Subjects:
Cell Therapy
Lymphoma
Immunotherapy
CAR-T
Chimeric Antigen Receptors
Online Access:https://www.paijournal.com/index.php/paijournal/article/view/647

Internet

https://www.paijournal.com/index.php/paijournal/article/view/647

Similar Items